(Q43585618)

English

Pharmacokinetic and safety profile of desloratadine and fexofenadine when coadministered with azithromycin: a randomized, placebo-controlled, parallel-group study

scientific article published in March 2001

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Pharmacokinetic and safety profile of desloratadine and fexofenadine when coadministered with azithromycin: a randomized, placebo-controlled, parallel-group study (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

0 references

1 reference

based on heuristic

inferred from title

pharmacokinetics

1 reference

based on heuristic

inferred from title

author name string

S Gupta

1

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

C Banfield

2

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

B Kantesaria

3

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

M Marino

4

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

R Clement

5

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

M Affrime

6

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

V Batra

7

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

publication date

1 March 2001

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Clinical Therapeutics

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

23

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

451-466

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Once-daily desloratadine improves the signs and symptoms of chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980049-7

7 January 2021

based on heuristic

inferred from DOI database lookup

The metabolism of antihistamines and drug interactions: the role of cytochrome P450 enzymes

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980049-7

7 January 2021

based on heuristic

inferred from DOI database lookup

P-glycoprotein inhibitor erythromycin increases oral bioavailability of talinolol in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980049-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Terfenadine-ketoconazole interaction. Pharmacokinetic and electrocardiographic consequences

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980049-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Changes in the pharmacokinetics and electrocardiographic pharmacodynamics of terfenadine with concomitant administration of erythromycin

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980049-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Interrelationship between substrates and inhibitors of human CYP3A and P-glycoprotein.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980049-7

7 January 2021

based on heuristic

inferred from DOI database lookup

The contribution of P-glycoprotein to pharmacokinetic drug-drug interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980049-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Arrhythmogenic mechanisms of non-sedating antihistamines

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980049-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Risk of torsades de pointes with non-cardiac drugs. Doctors need to be aware that many drugs can cause qt prolongation

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980049-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Lack of clinically relevant interaction between desloratadine and erythromycin

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980049-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Desloratadine has no clinically relevant electrocardiographic or pharmacodynamic interactions with ketoconazole

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980049-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0149-2918(01)80049-7

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43585618&oldid=2143298436"